Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

9.650 +0.010 (+0.10%)
Official Closing Price Updated: 7:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
EVH Stock Earnings: Evolent Health Beats EPS, Beats Revenue for Q1 2024
EVH stock results show that Evolent Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
In-Depth Examination Of 6 Analyst Recommendations For Evolent Health
 
Via Benzinga
Navigating 4 Analyst Ratings For Evolent Health
 
Via Benzinga
HIMS Stock Breaks Out On Powerful Turnaround Quarter
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum 
Via Investor's Business Daily
These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results
Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday. 
Via Benzinga
Analyst Scoreboard: 4 Ratings For Evolent Health
 
Via Benzinga
Evolent Health (EVH) Q4 2023 Earnings Call Transcript
EVH earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Evolent Health's Earnings: A Preview
 
Via Benzinga
Analyst Expectations for Evolent Health's Future
 
Via Benzinga
30 US States Pause Medicaid Disenrollment Due To Technical Glitch
The U.S. 
Via Benzinga
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Evolent Health (EVH) Q2 2023 Earnings Call Transcript
EVH earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Earnings Outlook For Evolent Health
 
Via Benzinga
Analyst Ratings for Evolent Health
 
Via Benzinga
Evolent Health (EVH) Q1 2023 Earnings Call Transcript
EVH earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. 
Via Benzinga
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Recap: Evolent Health Q1 Earnings
 
Via Benzinga
Evolent Health (EVH) Q3 2023 Earnings Call Transcript
EVH earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
 
Via Benzinga
Evolent Health (EVH) Q4 2022 Earnings Call Transcript
EVH earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Growing Number of Industries Realize the Urgency for Ransomware Protection
EQNX::TICKER_START (NASDAQ:HCTI),(NASDAQ:HCAT),(NYSE:EVH),(NASDAQ:DH),(NASDAQ:NXGN) EQNX::TICKER_END 
Via FinancialNewsMedia
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
 
Via Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
 
Via Benzinga
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.